Snapshot from Sep 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech medical research

Shared fatigue biology across five illnesses

Analysis based on 6 articles · First reported Sep 02, 2026 · Last updated Sep 05, 2026

Sentiment
10
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The study could boost Oxford BioDynamics' diagnostic platform credibility and open new markets for blood-based tests, potentially increasing its valuation. For the University of East Anglia and academic partners, the impact is reputational and may attract research funding, with limited direct market effect.

Biotechnology Healthcare

Researchers at the University of East Anglia and Oxford BioDynamics, with collaborators from the London School of Hygiene and Tropical Medicine and United Kingdom — Cornwall Partnership NHS Foundation Trust, published a study in the Journal of Translational Medicine revealing shared biological mechanisms underlying chronic fatigue in five conditions: ME/CFS, long Covid, PTSD, rheumatoid arthritis, and multiple sclerosis. Using Oxford BioDynamics' EpiSwitch Orion platform, they analyzed 3D genomic architecture and found that despite little direct genetic overlap, the conditions converge on common regulatory networks involving immune and inflammatory signaling, mitochondrial energy production, metabolic regulation, stress-response, and neuroendocrine signaling. The findings suggest a 'biological unifying theory of fatigue' and may lead to objective blood tests and cross-condition treatments. Lead researcher Dmitry Pshezhetskiy and Oxford BioDynamics' Ewan Hunter were key contributors.

70 Oxford BioDynamics provided platform
stock
Provided the EpiSwitch Orion platform used in the study. Positive validation of its technology could increase commercial interest and market value.
Importance 85.0 Sentiment 60.0
per
Lead researcher who articulated the unifying theory. His prominence is elevated in the field, potentially benefiting his institution.
Importance 80.0 Sentiment 10.0
per
Chief Data Officer at Oxford BioDynamics, explained the platform's role. His involvement underscores the company's technical contribution.
Importance 40.0 Sentiment 10.0
govactor
Collaborating NHS trust, providing clinical perspective. Minor reputational benefit.
Importance 20.0 Sentiment 5.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.